Dmk Pharmaceuticals Corporation
Pharmaceuticals, El Camino Real Ste 300, San Diego, , 92130, California, 11682, United States, 11-50 Employees
Phone Number: 85********
Who is DMK PHARMACEUTICALS CORPORATION
DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substan...
Read More
-
Headquarters: 11682 El Camino Real Ste 300, San Diego, California, 92130, United States
-
Date Founded: 2006
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from DMK PHARMACEUTICALS CORPORATION
DMK Pharmaceuticals Corporation Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding DMK Pharmaceuticals Corporation
Answer: DMK Pharmaceuticals Corporation's headquarters are located at El Camino Real Ste 300, San Diego, , 92130, California, 11682, United States
Answer: DMK Pharmaceuticals Corporation's phone number is 85********
Answer: DMK Pharmaceuticals Corporation's official website is https://adamispharmaceuticals.com
Answer: DMK Pharmaceuticals Corporation's revenue is $1 Million to $5 Million
Answer: DMK Pharmaceuticals Corporation's SIC: 2834
Answer: DMK Pharmaceuticals Corporation's NAICS: 325412
Answer: DMK Pharmaceuticals Corporation has 11-50 employees
Answer: DMK Pharmaceuticals Corporation is in Pharmaceuticals
Answer: DMK Pharmaceuticals Corporation contact info: Phone number: 85******** Website: https://adamispharmaceuticals.com
Answer: DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI (naloxone) and SYMJEPI. ZIMHI (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month